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red cell casts. These findings and her persistent hypertension
prompted the referral to our institution.
On physical examination her blood pressure was 165/92
mm Hg supine and 168/96 mm Hg standing; pulse, 88 beats/
min; respirations, 14 breaths/min. She was a well-developed
thin young woman with a healthy appearance. Funduscopic
examination revealed mild generalized arteriolar constriction
without hemorrhages or exudates. Her lungs were clear. The
cardiac rate and rhythm were normal; an S4 was present at
the apex. Liver and spleen were not enlarged, and she had no
edema, petechiae, or rash. The neurologic examination was
normal. The following studies were negative: ANA, anti-DNA,
anti-GBM, pANCA, cANCA, cryoglobulins, antiphospholip-
ids, anti-ENA, rheumatoid factor, and serologies for HBV,
HCV, and HIV. The C3 and C4 were now normal. The urine
again showed dysmorphic hematuria, pyuria, and cylindruria;CASE PRESENTATIONS
the urinary protein excretion was 2.7 g/day. The serum creati-
Patient 1. A 25-year-old female medical student was referred nine had risen to 2.6 mg/dL, and the creatinine clearance was
to IPEM-Gambro Healthcare clinics because of hematuria and 26 mL/min. Renal biopsy showed an increased number of cells
hypertension. She had been in good health except for a two- within the glomerular tuft, with occasional polymorphonuclear
year history of tension headaches for which she had taken leukocytes, capsular adhesions, mesangial sclerosis, and cellu-
various analgesics at a rate of no more than once or twice lar crescents in 3 of 14 glomeruli. The interstitium revealed
weekly. Her blood pressure, which had been measured on scattered mononuclear cell infiltrates. The vessels appeared
several occasions by her peers, was always normal. Eight weeks normal. Moderate (2) IgG and C3 granular deposits were
before consultation, she experienced a two-day episode of sore seen in the mesangium, capillaries, and in some tubules. Mini-
throat, mild fever, and swelling of local lymph nodes. Her mal amounts of IgM, IgG, and fibrin were present in some
complete blood count, blood urea, and urinalysis had been glomerular capillaries. She was treated with furosemide, 40 mg
normal; throat culture results were not available. Two weeks twice daily, enalapril, 10 mg once daily; and prednisone, 60
before consultation, she developed one of her frequent head- mg/day for four weeks and then a slow taper. Her blood pres-
aches and her blood pressure was 150/100 mm Hg. The rest sure fell to an average of 115/78 mm Hg, the serum creatinine
of the physical examination was normal. Her physician initiated stabilized at about 2.3 mg/dL, and the urinary protein excretion
10 mg of enalapril per day and ordered laboratory tests. She rate fell to less than 300 mg/day. The prednisone was slowly
had a normal hematocrit (41%) and platelet (210,000/mm3) tapered. Her proteinuria and renal function have remained
and leukocyte count (7800/mm3, with a normal differential). stable.
Serum electrolytes and calcium were normal, but the serum
Patient 2. A 24-year-old woman was referred to our institu-
creatinine was 1.8 mg/dL. The ASO and ANA were negative, tion because of nephritis due to systemic lupus erythematosus
and serum complements were low (C3, 83 mg/dL; C4, 10 mg/ (SLE). The SLE, which had been diagnosed 2 years before
dL). The urinalysis showed 3 protein, 4 blood, red blood referral, was manifested by malar rash, alopecia, oral sores,
cells too numerous to count, many leukocytes, and granular and and pancytopenia. Her blood pressure was reportedly 115/75
mm Hg. She had had renal involvement since her diagnosis;
the urinalysis consistently had few dysmorphic red cells andThe Nephrology Forum is funded in part by grants from Amgen,
proteinuria that had progressed from 60 mg/day at presentationIncorporated; Merck & Co., Incorporated; Dialysis Clinic, Incorpo-
to an average of approximately 1000 mg/day at the time ofrated; and Bristol-Meyers Squibb Co.
referral. The creatinine clearance was stable at 110 mL/min.
Key words: glomerulonephritis, edema, volume expansion, cortical col- Her rheumatologist initially treated her with prednisone (40
lecting duct, ENaC, Na/K-ATPase, hypertension. mg/day for 2 weeks followed by a slow taper) and hydroxychlor-
oquine. Because her systemic manifestations persisted, she was 2002 by the International Society of Nephrology
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given azathioprine for 4 months followed by dapsone, in addi- two young women illustrate the difficulty that one en-
tion to the continuing prednisone (15 mg/day), but without counters when trying to optimize blood pressure control
obvious benefit. She also was given lisinopril, 5 mg/day, for in patients with glomerulonephritis (GN). Both patients
the proteinuria.
presented with hypertension, hematuria, and protein-Physical examination disclosed a blood pressure of 130/65
uria, the classic clinical triad of GN. The first case con-mm Hg without orthostatic changes. She had a marked malar
cerns a young woman who developed an endocapillaryrash extending from her hairline down her neck. Alopecia was
present in a patchy distribution, and she had numerous buccal proliferative GN that was likely due to a postinfectious
ulcers. The remainder of the examination was normal. nephritic process. Indeed, she had a recent history of
Laboratory studies revealed a hemoglobin of 9.8 mg/dL; sore throat, fever, and normal urinalysis and blood urea,
leukocyte and platelet counts were 2700 and 109,000/mm3, re- followed several weeks later by clinical signs of GN and
spectively. Serum electrolytes were normal and the serum cre-
decreased serum complement. The negative serologicatinine was 1.0 mg/dL. The complement components were low
studies make other forms of nephritis less likely. The(both C3 and C4 were below the limits of detection), and the
precise time of onset of her GN is hard to define, butdouble-stranded DNA was 500 IU/mL. She was treated with
1 mg/kg/day of prednisone for 2 months followed by a slow the course appeared to be rather aggressive, causing a
taper. Her SLE improved transiently, but 6 months later the rapid decline in her renal function. Combining an angio-
serum creatinine had increased (1.5 mg/dL), her blood pressure tensin-converting-enzyme (ACE) inhibitor with a di-
was 150/100 mm Hg, and the proteinuria and dysmorphic hema- uretic easily controlled her hypertension. The second
turia had worsened significantly. Renal biopsy disclosed diffuse
patient has a clear diagnosis of systemic lupus erythema-proliferative and necrotizing glomerulonephritis (WHO stage
tosus (SLE) that was complicated by lupus nephritis.4A) with a membranous nephropathy component (WHO stage
Her renal disease presented as a mixed diffuse prolifera-5). Monthly intravenous cyclophosphamide was initiated, her
prednisone was again increased to 1 mg/kg/day, and the lisino- tive and membranous GN. Despite stabilization of her
pril was titrated up to 20 mg/day. With this therapy, her blood renal function at a level almost twice that of Patient 1
pressure dropped to 130/80 mm Hg, the serum creatinine gradu- and remission of her lupus, she has refractory hyperten-
ally fell to 1.1 mg/dL, and all the laboratory parameters of SLE sion that is currently marginally controlled despite her
improved. Three months into the cyclophosphamide therapy,
taking five antihypertensive medications.despite complete resolution of extrarenal manifestations of
In GN, blood pressure can range from normal to ex-SLE, she was admitted for severe hypertension during a flare
tremely high levels and can be accompanied by poten-of her lupus nephritis. Her blood pressure had increased to
tially lethal hypertensive encephalopathy. More impor-230/120 mm Hg, she had moderate edema of her legs, the serum
creatinine and double-stranded DNA again had increased (to tant, however, is the relentless arterial hypertension that
2.7 mg/dL and500 IU/mL, respectively), and the complement occurs in most cases and that markedly influences the
had again fallen to undetectable levels. Urinalysis revealed evolution of the GN [1]. In fact, hypertension is frequent,
marked dysmorphic hematuria and worsening proteinuria (3.8 and its negative effects on renal function have been de-g/day). Her blood pressure was controlled by enforcing a re-
scribed in acute postinfectious GN [2], IgA nephritis [3],stricted sodium diet (90 mEq/day), and by adding furosemide
lupus nephritis [4], membranous nephropathy [5], and(40 mg twice daily) and amlodipine (10 mg/day). Her SLE
minimal change disease [6]. Because of these harmfulnephritis flare was treated with pulse methylprednisolone (1
g/day for 3 days). The serum creatinine stabilized at 2.2 mg/dL effects of hypertension, many investigators have strongly
(creatinine clearance of 43 mL/min) and the hematuria re- recommended aggressive antihypertensive therapy [7].
solved, but her proteinuria persisted (5 g/day). After the The agents recommended, however, have varied widely
6-month course of cyclophosphamide was completed, she was from diuretics [8], to calcium channel antagonists [9], to
given mycophenolate mofetil (500 mg/day) for long-term main-
drugs that interfere with the renin- angiotensin systemtenance therapy. Because of her refractory hypertension and
[10]. These varied approaches are the result of our poorproteinuria, the following medications were sequentially added
understanding of the renal mechanisms leading to the(and the doses titrated) so that she is currently taking: lisinopril,
development of hypertension in glomerular diseases.60 mg/day; candesartan [an angiotensin II type 1 (AT1) recep-
tor blocker], 32 mg/day; amlodipine, 10 mg/day; furosemide, Nevertheless, most investigators favor the use of ACE
80 mg twice daily; and clonidine, 0.3 mg twice daily. At latest inhibitors because of the well-shown renal protective
follow-up (12 months later), her blood pressure remained mar- actions of these drugs, actions that at least in part might
ginally controlled (systolic pressures range from 125 to 150 be independent from the blood-pressure-lowering ef-
mm Hg and diastolic pressures are at 75 to 90 mm Hg), her
fects. At any rate, normalization of blood pressure is arenal function is stable (serum creatinine, 2.3 mg/dL), and her
must if the kidney as well as the heart and blood vesselsproteinuria shows modest improvement (2 g/day).
are to be protected. To accomplish control, though, the
mechanisms that contribute to the increased blood pres-
DISCUSSION sure in the nephritic syndrome must be understood. In
Dr. Luis I. Juncos (Section of Nephrology, IPEM- discussing these mechanisms, I shall leave out end-stage
Gambro Healthcare and IV Department of Medicine, Na- renal disease and those clinical situations in which the
glomerular filtration rate (GFR) is so low that any othertional University of Cordoba, Cordoba, Argentina): These
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mechanism is irrelevant. I will include, however, all other could not explain the salt-retaining state of the experi-
mental animal). This notion of diminished proximal tu-forms of GN (immunologic, toxic, with short or pro-
longed clinical courses, etc.). Although in all these situa- bular sodium reabsorption in the puromycin nephritis
model is also supported by several studies on isolatedtions GN can produce altered vascular reactivity, most
evidence points to a major role of salt retention in the microperfused tubules [20]. Similar decreases in proxi-
mal tubular sodium reabsorption have been shown inproduction of the hypertension [11–13]. Thus, I will focus
mainly on this aspect of the hypertension in this Forum. other models of GN. For instance, significantly decreased
fractional and absolute proximal tubule reabsorption
What site along the nephron is responsible have been reported in rats with autologous immune com-
for increased Na retention? plex nephritis [21], rats with nephrotoxic serum nephritis
[20], and in a milder form of the same nephrotoxic modelAs I said, the hallmark of hypertension associated with
GN appears to be increased salt retention. Sometimes without proteinuria [22]. So overall, little evidence points
to the proximal tubule as the likely site of the augmentedGFR has decreased to such a low level that it is the
obvious culprit of the salt retention; however, in many sodium retention, at least during experimental GN.
Having ruled out the proximal tubule as the sourcecases the role of GFR is not as obvious [12, 14]. To begin
with, studies by Ichikawa et al looked at the role of GFR of sodium retention, the thick ascending loop of Henle
(TALH) appeared as a logical candidate. However, Ichi-on sodium retention in a rat model of GN, puromycin-
induced nephrotic syndrome [15]. Puromycin markedly kawa et al failed to show increased sodium reabsorp-
tion in superficial loop segments [15], and Bernard etdecreased GFR and caused a marked retention of so-
dium. This decline in GFR probably arose from de- al reached similar conclusions in segmental analysis of
tubular sodium reabsorption in volume-expanded ratscreased renal blood flow and Kf [16] and likely was due
to local effects of puromycin rather than to systemic with autologous immune-complex nephritis [21]. Thus,
it would appear that neither the proximal tubule nor thechanges (for example, hypoalbuminemia, changes in sys-
temic hemodynamics) because infusing puromycin into TALH takes part in the increased sodium reabsorption
observed during experimental GN. These experimentsonly one kidney caused GFR and sodium excretion to
fall in the ipsilateral, but not in the contralateral, kidney. could not rule out the possibility that the abnormal salt
retention occurred in the deep nephrons, which are notInterestingly, the contralateral kidney did not fully com-
pensate with a greater sodium excretion, although there accessible by standard micropuncture techniques, how-
ever. Buerkert et al addressed this possibility by studyingis still some controversy in this point [17]. Be that as it
may, the fall in GFR in the puromycin-infused kidney sodium handling in the deep nephrons and the terminal
collecting duct in a rat model of anti-GBM nephritisprobably results from the action of angiotensin II (Ang
II) because infusing saralasin reversed the decline in and found no differences between deep and superficial
nephrons [23]. Therefore, in these experimental models,GFR [15]. However, the reduction in GFR in puromycin
nephritis does not appear to be a requirement for salt the increased sodium reabsorption is likely located at
the cortical collecting (CCD) or medullary collectingretention; the improvement in GFR by saralasin failed
to increase sodium excretion. In fact, most studies show duct (MCD).
Several lines of evidence point to the CCD as thethat sodium excretion falls to a greater extent than does
GFR [18, 19]. Taken together, these studies suggest that principal locus of sodium retention in these models of
experimental GN. First, micropuncture studies by Ber-the fall in GFR is not likely responsible for the increased
sodium retention. nard et al found that the CCD is the only site of the
nephron where sodium reabsorption is increased [21].Because abnormal GFR is not likely the reason for
the sodium retention, it follows that abnormal tubular Moreover, chemical medullectomy with bromoethylam-
ide, an agent that causes salt wasting and severe damagereabsorption must be of primary importance. Thus, the
next step is to identify which tubular segment(s) are to the inner MCD, does not prevent the sodium retention
of puromycin nephritis [24]. Furthermore, several studiesresponsible for the abnormal sodium retention. Several
lines of evidence argue against the proximal tubule being have found increased Na/K ATPase activity in the
CCD in various forms of nephritis. Because the activitythe primary site of sodium retention. For instance, in
Ichikawa’s study, GFR was decreased, as was the abso- of the Na/K ATPase is closely related to sodium reab-
sorption, these studies support increased sodium reab-lute volume of tubular fluid reaching the end of the
proximal convoluted tubule [15]. But the rate of proximal sorption in the CCD during experimental GN. For in-
stance, Vogt and Favre [25] and Feraille et al [26] havetubular reabsorption also was diminished (despite the
decreased absolute volume of delivered tubular fluid). shown an increase in Na/K ATPase activity (as ex-
pressed by an increase in enzyme turnover) in rats withThus, the decreased delivery of tubular fluid volume
from the proximal tubule likely was due to the decreased puromycin nephritis. This effect was limited to the col-
lecting duct; the Na/K ATPase activity and transportGFR (although, as I already mentioned, the fall in GFR
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In addition to the increased sodium retention of the
CCD induced by GN, the more distal MCD also might
contribute to sodium retention. Ideally, in the presence
of increased upstream sodium retention, the MCD should
be able to compensate by decreasing its own sodium re-
absorption. However, this does not appear to be the case.
In fact, there is reportedly medullary resistance to the
natriuretic action of atrial natriuretic peptide (ANP) dur-
ing experimental GN. In both puromycin and adriamycin
nephropathies, the levels of ANP are elevated, but the
sensitivity to ANP is markedly decreased [29, 30]. This
resistance could be due to a more marked activation of
phosphodiesterase, which is responsible for catabolism
of cGMP, the second messenger of ANP [31]. The MCD
also might contribute to the abnormal fluid-retaining
effect in GN. In this respect, it is interesting that inner
MCD cells have been implicated in a different model of
salt sensitivity, that is, in the Dahl salt-sensitive hyper-
tensive rat [32]. Cultured inner MCD cells from Dahl
salt-sensitive rats have greater sodium transport than
do inner MCD cell monolayers from their salt-resistant
counterparts. Thus, it is conceivable that this increased
sodium transport in the MCD cells from salt-sensitive
rats also could occur in GN and be mediated by any of
the several mechanisms that normally regulate sodium
reabsorption in this tubular segment. Although a disor-
der in sodium handling in the MCD remains a prospect,
increased CCD sodium transport best accounts for salt
Fig. 1. Na/K ATPase activity in proximal convoluted tubule (PCT), retention in nephritis. In this respect, several mediators
thick ascending limb (TAL), and cortical collecting duct (CCD) in two are potential stimulators of either a basolateral or apicalmodels of experimental nephritis: (A) rats and (B) mice. (A) Values
membrane mechanism of increased sodium reabsorptionobtained 7 days after administration of puromycin () or vehicle ()
to Sprague-Dawley rats. (B) Values obtained in 4-month-old MRL  in GN.
BXSBYaaF1 hybrid mice, a model of spontaneous lupus-like glomerulo-
nephritis (), and their controls [MRL  BXSBYaa-F1 hybrid mice Potential mechanisms for increased sodium()].
reabsorption in the CCD
Sodium reabsorption in the CCD occurs via a two-
step mechanism: first sodium enters the cell from thecapacity were increased on day 7 in the CCD but not in
lumen through apical epithelial sodium channels (ENaC),the TALH (Fig. 1). Similar findings have been reported
thus increasing intracellular sodium concentration. Thenin MRL  BXSBYaa F1 mice, which develop a sponta-
Na/K ATPase, located on the basolateral membrane,neous lupus-like GN [27]. At four months of age, when
pumps the sodium out of the cell into the general circula-nephritis is evident, these animals show a normal Na/
tion [33]. Thus, it follows that increased sodium reab-K ATPase activity in the proximal convoluted tubule
sorption can result from either increased activity of theand in the TALH. However, in the CCD of diseased
ENaC with secondary activation of the Na/K ATPase,mice, the Na/K ATPase activity was more than twice
as occurs in Liddle’s syndrome, or from a primary stimu-as high as that in control mice (Fig. 1). Finally, Decheˆnes
lation of Na/K ATPase with a secondary increase inand Doucet found that Na/K ATPase activity in CCD
sodium influx due to the favorable electrochemical gradi-was stimulated each time sodium balance became posi-
ent. Feraille et al have suggested that the defect in experi-tive in three different models of GN [28]. In their study,
mental GN is an increase in the activity of the Na/Kpump activity correlated inversely with urinary sodium
ATPase because increasing cellular sodium concentra-excretion. These studies show that sodium reabsorption
tion upregulates the Na/K ATPase pump [26]. Thus,or activity of the Na/K ATPase pump is increased in
if the apical sodium channels primarily allowed a largerCCD in several models of both chemical and immune
amount of sodium to enter the cell, the number of pumpsglomerular injury, and thus identifies the CCD as a likely
also should be increased. But this was not the case inprimary site responsible for the increased sodium reten-
tion associated with experimental GN. their study, where they found an increase in the activity
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of Na/K ATPase with low ouabain sensitivity, without RAS [40]. Finally, it is important to point out that the
apparently poor antihypertensive action of ACE inhibi-an increase in the number of pumps. Whether this intri-
guing finding is common to most types of GN or whether tors in GN should be dissociated from their reported
antiproteinuric and renoprotective effects. The mecha-it is the predominant mechanism requires further study.
However, regardless of whether the increased activity nisms by which ACE inhibitors and Ang II receptor
blockers are protective have been extensively reviewedlies in the ENaC or in the Na/K ATPase, several
factors could alter the function of either of these entities. [41].
Aldosterone. Because the likely locus of the sodiumRenin-angiotensin system. The renin-angiotensin sys-
tem (RAS) is one of several proposed culprits that poten- retention in GN is the CCD, aldosterone naturally was
considered a potential mediator of the exaggerated so-tially cause increased sodium reabsorption. Indeed, in
puromycin nephritis, high concentrations of angioten- dium retention. Indeed, some indirect evidence supports
a role for mineralocorticoids in clinical and animal mod-sinogen are transiently found very early before the ap-
pearance of proteinuria [34]. But GN usually evolves els of glomerular diseases accompanied by heavy pro-
teinuria [39, 42–44]. However, other more direct evi-with signs of fluid retention and suppression of the RAS
system [8, 12] and decreased gene expression of AT1 dence negates a role for aldosterone in sodium retention
in GN, even in the presence of nephrotic syndrome. Forreceptors in the kidneys [35]. Yet despite this suppression
of the RAS, it may be that the Ang II levels still are instance, in experimental GN, the abnormality in Na/
K ATPase activity is independent of aldosterone [25].inappropriately high for the degree of sodium expansion.
If so, blocking a step of the RAS could be effective in Furthermore, fluid retention occurs in nephrosis due to
rabbit anti-rat kidney serum, despite normal aldosteronereducing blood pressure. Confirming this notion, Parra
et al attained rapid control of hypertension in patients levels [45], and in unilateral models of adriamycin and
puromycin nephritis, only the affected kidney retainswith acute GN treated over the short term with captopril
[36]. In this study, the patients treated with the ACE sodium [15, 29]. Finally, patients can develop edema
despite normal plasma aldosterone [46], and neitherinhibitor showed a rise in urinary PGE2 and kinins, both
of which blunt the effects of Ang II. Furthermore, Hisada ACE inhibition nor adrenalectomy prevents the sodium
retention in nephrotic patients and in puromycin nephri-et al, using a standard model of anti-GBM GN in Ang
II type 1a receptor-deficient mice, showed that only tis [44, 45, 47]. Thus, in most GN with or without heavy
proteinuria, little evidence supports a role for aldoste-AT1a/ mice develop hypertension and proteinuria,
even though AT1a/ mice had similar glomerular aggre- rone in nephritis-induced sodium retention.
Sympathetic nervous system. Another hypertensive sys-gation of autologous antibodies [37]. Both these studies
thus support a role for the RAS. tem that could contribute to sodium retention in GN is
the sympathetic nervous system (SNS). It is well knownNot all studies are in agreement, however. For instance,
Gabbai et al found that the ACE inhibitor quinapril that the SNS participates in the control of sodium excre-
tion. Normally, during periods of increased salt intake,corrected the hypertension associated with 2-kidney,
1-clip Goldblatt hypertensive rats, but not if anti-GBM- suppressed sympathetic outflow results in vasodilation
and natriuresis. This sodium-induced sympatho-inhibi-induced GN was superimposed on 2-kidney, 1-clip Gold-
blatt hypertension [38]. However, because the animals tion is impaired in some animal models of salt-dependent
hypertension [48]. For instance, sympathetic activity iswith GN had a paradoxical rise in the blood levels of
Ang II during ACE inhibition, an alternative path- increased in patients with various forms of chronic renal
disease [49] and in rats with diminished renal mass [50],way for Ang II formation that is refractory to ACE
inhibition cannot be excluded. In preliminary studies all conditions with salt-dependent hypertension. In GN
a role for the SNS is implied by studies in adriamycin-done in our laboratory, we also found that quinapril
had no effect on blood pressure levels when given to induced nephropathy. In this model, renal denervation
reverses blunted natriuretic responses to ANP [51]. Inhypertensive rats with puromycin nephritis (unpublished
data). Pedraza-Chaverri et al also found no correlation addition, in experimental anti-GBM GN, Blantz et al
found that 2 adrenergic signals are required for comple-between sodium retention and plasma renin activity or
plasma renin concentration [39]. And as I mentioned ment-mediated renal vasoconstriction [52]. Despite these
reports, it remains to be shown that salt sensitivity isbefore, saralasin increases GFR and single-nephron
GFR during unilateral puromycin nephritis but does not neurogenically mediated in the nephritic syndrome.
Vasopressin. Vasopressin is another candidate thatimprove natriuresis in the ipsilateral kidney [15]. Thus,
the RAS decreases GFR but probably contributes little might help explain sodium retention and hypertension
in GN. In in vitro experiments, vasopressin stimulatesto salt retention in this model, and the role of the RAS
in GN has been difficult to define. The exception is the Na/K ATPase activity in CCD [53]. Chronic adminis-
tration of vasopressin increases Na/KATPase activitynephritis associated with vasculitis, in which hyperten-
sion can result from ischemia-induced activation of the in CCD in Brattleboro and Sprague-Dawley rats but
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has no effect on medullary ducts [54, 55]. Furthermore, monal response to ANP seems normal in patients with
nephrosis [61].plasma levels of vasopressin and vasopressin RNA ex-
Kallikrein-kinin-system, prostaglandins, and nitric oxide.pression in the hypothalamus are increased in puromycin
The kallikrein-kinin-system, prostaglandins, and NO arenephritis [56]. This rise is associated with an 87% de-
important modulators involved in the control of renalcrease in aquaporin-2 and a 70% decrease in aqua-
hemodynamics and volume homeostasis and thus alsoporin-3 expression only in the inner medulla. Conse-
have been considered potential candidates in mediatingquently, increased Na/K ATPase activity in CCD
the abnormal sodium retention during GN. Normally,could result from elevated plasma vasopressin levels.
stimulation of the bradykinin B2 receptor, the predomi-However, Descheˆnes and Doucet showed that the ad-
nant receptor under normal conditions, causes renal va-ministration of puromycin in Brattleboro rats, which lack
sodilation and natriuresis. Thus, if kinin activity is low,vasopressin secretion, increases Na/K ATPase activ-
increased vasoconstriction and sodium retention can be-ity, as it does in Long Evans rats (abstract; Descheˆnes
come apparent. Indeed, many years ago, Glasser andet al, J Am Nephrol 8:493A, 1997) [28].
Michael found low urinary kallikrein excretion in ratsStimulation of these various vasopressor systems might
with puromycin nephritis and in anti-GBM disease [62],contribute to sodium retention in GN, but more studies
and Colina-Chourio et al reported similar findings in theare needed to define their role. On the other hand, inhibi-
early phase of acute GN [63]. These studies raise thetion of vasodepressor hormones also could prompt so-
question of whether the decrease in kinins is responsibledium reabsorption. It is well known that hypertension
for the abnormal renal responses in these models of GN.in Dahl salt-sensitive rats maintained on a high-salt diet
However, the urinary excretion of kinins remains lowis due to a rise in peripheral and renal vascular resistance
not only throughout the clinical course but also well into[57]. This contrasts with the decreased resistance seen
convalescence, when abnormal renal sodium handlingin normal rats given a high-salt diet. Hypertension in salt-
is no longer present; thus it becomes more difficult tosensitive animals therefore could result from impaired
interpret these results. Furthermore, inflammation in-production of vasodilators such as ANP, the kallikrein-
duces the bradykinin B1 receptor to the point that itskinin system, prostaglandins, and nitric oxide (NO).
effects can predominate over those of the B2 receptor,Atrial natriuretic peptide. Plasma ANP concentration
and thus cause renal vasoconstriction and antinatriuresis.increases in patients with acute GN [58]. This rise in
If this is so and the kinins are low, then one wouldANP levels seems to be an appropriate response to the
expect the opposite results, that is, natriuresis and lessfrequent volume expansion of acute GN [12]. However,
vasoconstriction. This profile is clearly not consistentin patients with heavy proteinuria the situation is more
with what we see during GN. Until further studies using
complex. About one-third of them have low plasma vol-
specific kinin antagonists are performed, the role of ki-
ume and low ANP levels. That the remaining two-thirds nins will remain elusive.
show high ANP and low plasma renin activity suggests The role of prostaglandins is even less clear. Although
volume expansion. The normalization of ANP and renin their role in modulating renal function during the euvo-
activity after diuresis or after the resolution of the clinical lemic state is not crucial, their importance increases
picture supports the notion of compensatory hormonal markedly in situations of abnormal renal vasoconstric-
changes. Nevertheless, the elevation of ANP in GN tion, in particular during states of altered volume homeo-
might be due to an inappropriate tubular response. In- stasis. Early in the course of acute post-streptococcal
deed, ANP-induced natriuresis is blunted in rats with GN, urinary PGI2 and PGF2 are low and remain so
adriamycin and puromycin nephropathies [29, 51, 59], after the GN has subsided and an adequate diuresis has
and inner MCD (IMCD) cells from rats with adriamycin occurred [63]. The meaning of this low urinary prosta-
nephropathy are resistant to ANP [31]. This resistance glandin excretion is unknown. It is interesting that renal
to ANP seems unrelated to changes in receptor density prostaglandins are formed by cyclo-oxygenase (Cox) 1
or affinity in the inner stripe of the outer medulla or in or 2. Cyclo-oxygenase 2 is modulated by dietary intake
the inner medulla. On the whole, a post-receptor abnor- of sodium and is markedly stimulated by inflammatory
mality is suggested. This abnormality could be either a states. Results from ongoing studies with the newer Cox
higher activity of cyclic nucleotide phosphodiesterase 2 inhibitors should shed new light on the role of prosta-
[31] or lesser accumulation of cGMP (as in rats with glandins in GN.
Heymann nephritis) [60]. Whatever the mechanism of On the other hand, NO plays a critical role in many
resistance to ANP, the defect could limit the natriuretic renal processes (immunity, inflammation, hormone se-
ability of the kidney or could limit the IMCD from com- cretion, RNA synthesis, and glomerular and medullary
pensating for the increased sodium reabsorption in the hemodynamics). Nitric oxide blunts tubuloglomerular
CCD. These exceedingly interesting findings have yet to feedback response (pre-glomerular vasoconstriction and
fall in GFR after increased NaCl delivery to the maculabe confirmed, particularly because the renal and hor-
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sis [72]. Whether NO deficiency could decrease Na/K
ATPase activity in GN needs to be clarified.
Other factors. In addition to these vasoactive auto-
coids, other factors such as proteinuria and interstitial
inflammation have been proposed as causes of sodium
retention in GN [73]. However, sodium retention has
been clearly dissociated from proteinuria in puromycin,
adriamycin, and HgCl2 models of GN [26, 70]. Further-
more, severe proteinuria without sodium retention can
occur in Heymann nephritis and serum sickness nephritis
[74]. Therefore, proteinuria in GN is independent from
sodium retention and Na/K ATPase activity (abstract;
Descheˆnes G, J Am Soc Nephrol 8:493A, 1997) [26].
Similarly, the fibrosis of most tubular interstitial diseases
is associated with salt wasting [73] and the cytokines
produced by infiltrating cells [75] have not been shown
to cause sodium retention. Indeed, interleukin 1, the
Fig. 2. Percent changes in renal blood flow after intrarenal artery ad- cytokine most studied in GN, is natriuretic. All in all, it
ministration of increasing doses of acetylcholine. Values were obtained doesn’t seem likely that interstitial fibrosis can directly
2 (acute) and 14 (chronic) days after intraperitoneal administration of
account for the abnormal sodium retention of GN.puromycin to Sprague-Dawley rats. HSD and NSD denote high (4%)
and normal (0.4%) sodium diets. Symbols are: () normal control; () In summary, volume expansion likely is the main rea-
acute NSD; () acute HSD; () chronic HSD; ( ) chronic NSD; *P  son for hypertension in the various forms of nephritic
0.05 compared to control animals.
syndrome. This expansion is due to an exaggerated tubu-
lar reabsorption rather than to a decreased rate of filtra-
densa). In this way, NO can help maintain natriuresis tion (Fig. 3). Most evidence indicates that sodium reten-
during salt loading [64]. Of interest, NO inhibits sodium tion occurs in the CCD, where Na/K ATPase is
entry into CCD cells. This effect results not from inhibi- activated. What causes stimulation of Na/K ATPase
tion but rather through increased permeability of apical pumps remains to be defined. It appears that the primary
sodium channels [65]. In contrast, in other tubular seg- insult to the glomerulus generates either a direct (via
ments, NO is capable of inhibiting Na/KATPase activ- release of paracrine factors) or indirect response that
ity [66]. In any case, insufficient NO synthesis could play leads to the abnormal sodium retention.
a key role in salt sensitivity. In fact, Dahl salt-sensitive
rats show marked reduction of endothelium-dependent
QUESTIONS AND ANSWERSrelaxation that points to impaired generation of NO [67].
Likewise, we found endothelial dysfunction early in radi- Dr. Nicolaos E. Madias (Executive Academic Dean,
Tufts University School of Medicine, Boston, Massachu-ation nephritis, also a model of salt-sensitive hyperten-
sion [68]. Thus, it seems reasonable to suspect NO defi- setts, USA): Is there evidence from animal models or
human disease that the incidence and severity of hyper-ciency in GN, particularly because mesangial cells and
tubular epithelial cells can induce the expression of iNOS tension vary in different types of glomerulonephritis,
for example, proliferative versus nonproliferative, but atin response to inflammation [69–71] and thereby sup-
press eNOS and cause vasoconstriction. Direct immuno- similar levels of GFR?
Dr. Juncos: I am unaware of any study that was spe-logic or chemical damage to the endothelium also could
impair NO synthesis. Despite these arguments, few stud- cifically designed to compare the incidence or severity
of hypertension in the different forms of GN, particularlyies have looked at the potential contribution of NO. In
preliminary studies in puromycin nephritis, we found an when normalizing for GFR. However, several studies
that have looked at the epidemiology of GN in differentabnormal renal vascular response to acetylcholine (Fig.
2). This alteration was present as early as 48 hours after regions of the world suggest that hypertension is more
frequent and more severe in GN associated with vasculi-intraperitoneal administration of puromycin, when the
animals had not yet developed hypertension or protein- tis, in chronic proliferative GN, and in focal sclerosis,
albeit the reported incidence range is quite large, be-uria, and was worse at 2 weeks when proteinuria was
subsiding. These findings at least partly explain the salt tween 20% and 60%. On the other hand, membranous
GN and minimal change disease have an incidence ofsensitivity in this model. Nonetheless, plasma, urine, and
aortic endothelial cells of rats with puromycin nephritis hypertension of 7% and 15%, respectively [76]. It is
encouraging that the incidence and severity of hyperten-show increased asymmetrical dimethylarginine (ADMA),
a naturally occurring endogenous inhibitor of NO synthe- sion seem to be declining in all forms of GN, perhaps
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Fig. 3. Proposed mechanisms of sodium re-
tention in the nephritic syndrome. A toxic or
immunologic insult causes glomerular injury,
which can cause inappropriate release of en-
dothelial and/or mesangial vasoactive factors.
These glomerular factors then increase so-
dium reabsorption in the collecting duct.
because of early and better use of low-salt diets and peutics, University College Dublin, Mater Misericordiae
Hospital, Dublin, Ireland): You presented compellingdiuretics, as well as the larger antihypertensive arsenal
we now have available. Hopefully, this better control evidence for a local problem with sodium excretion in
the CCD and presented evidence for an increase in Na/will translate into improved long-term prognosis.
Dr. Madias: You suggested that NO deficiency plays K ATPase activity in this segment. I was intrigued by
your reference to a paper reporting reduced tissue PGE2a major role in the sodium retention of GN. Does NO
have effects on distal sodium transporters, for example, levels in this area [63]. Have the activity or messenger
RNA for Cox 1 and 2 been assessed in the CCD of theENaC or thiazide-sensitive Na/Cl cotransporter?
Dr. Juncos: Yes, nitric oxide can directly alter sodium nephritic kidneys?
Dr. Juncos: The CCD expresses both Cox 1 and Coxtransport in several nephron segments. For instance, in
the proximal tubule, NO inhibits Na/H exchange, Na/ 2 [85], but I do not know of any studies that have found
any changes in their mRNA expression or in cyclo-oxy-KATPase activity, and paracellular permeability [77, 78].
It also inhibits NaCl absorption as well as HCO3 flux in genase activity in the CCD during GN. Most studies
have focused on glomerular expression of these enzymesisolated, perfused rat thick ascending limb of Henle
[79, 80]. In the cortical collecting duct (CCD), NO de- during experimental GN and have found increased ex-
pression of either enzyme, depending on the experimen-creases both sodium transport and water permeability.
Indeed, NO decreases sodium transport both in isolated tal model of GN used [86, 87]. The increase in glomerular
Cox 1 might contribute to resolution of the disease,perfused CCD and in a CCD cell line [65, 81], and this
inhibition appears to be due to blocking of amiloride- whereas increased Cox 2 is accompanied by increased
thromboxane, rather than increased PGE2, and thussensitive sodium channels. No significant effect of NO
on Na/K ATPase activity was observed. Lu et al found might exacerbate the illness [88, 89]. Certainly, this is an
area that needs further study, in particular because thethat NO inhibits the low-conductance (6-pS) amiloride-
sensitive sodium channel and proposed that this effect low urinary excretion of PGE2 persists well into convales-
cence, the meaning of which is hard to understand.is due to hyperpolarization of the cell (NO-stimulated
basolateral K channels) [82, 83]. Finally, Stoos and co- Dr. Claudio Mascheroni (Division of Renal Medi-
cine–Hospital Centenario–Universidad Nacional de Rosa-workers showed that NO blunts ADH-stimulated water
and sodium transport in CCD by activating guanylate rio, Rosario, Argentina): Why does a lesion in the glomer-
ulus elicit abnormal sodium reabsorption in the CCD?cyclase [84]. The resulting increase in cGMP activates
protein kinase G (PKG), thereby decreasing cAMP con- Does the GN affect the CCD? That is, is there a lesion
present in this segment as well? If not, could you pleasetent. However, because the tubular fluid entering the
CCD is hypotonic, the changes in osmotic water perme- speculate as to the mechanisms by which glomerular
diseases induce sodium retention in the CCD?ability (Pf) are likely to be more important than the
inhibition in sodium transport [84]. Dr. Juncos: I do not know of any specific lesion to
the distal nephron caused by GN, and I know of no dataDr. Hugh Brady (Professor of Medicine and Thera-
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that show the mechanism by which the glomerular lesion crodissecting the nephron segments have described this
relationship. In fact, I am told that sometimes it is quiteinduces sodium retention in the CCD. However, it is
tempting to speculate that the events going on in the difficult to separate these segments when dissecting. I
must admit, however, that this relationship has not beenglomerulus are sending signals to the distal nephron that
in turn alter sodium transport. For this to occur, two gen- consistently observed in histologic studies. Thus, how
consistent this relationship is requires more study. Ineral criteria have to be met. The first is that the glomeru-
lar (or cells present therein during GN) must be capable any event, the close proximity of these segments of the
distal nephron and the glomerulus raises the possibilityof generating substances that modify tubular function.
In this respect, we already know that the glomerulus is that factors generated in the glomerulus during GN ei-
ther diffuse to the adjacent distal nephron segments ora very active synthetic structure and produces many bio-
logically active factors (for example, NO, prostaglandins, trigger a signaling cascade in these segments, and that
either of these scenarios ultimately might increase so-platelet activating factor, thromboxane) in response to
physiologic and pathophysiologic stimuli. Thus the first dium reabsorption in the affected segment.
Dr. Rosa Scuteri (Nephrologist, Department of Inter-criterion is met. In fact, it has already been shown that
glomerular-derived NO and prostaglandins regulate the nal Medicine, Universidad Nacional de Buenos Aires,
Buenos Aires, Argentina): Are the products released dur-vascular tone of the efferent arteriole [90, 91]. However,
the glomerulus and the efferent arteriole have a relation- ing GN-induced inflammation involved in the sodium-
retaining process?ship of immediate vascular continuity that makes it easy
to envision the glomerulus regulating efferent arteriolar Dr. Juncos: There seems to be a relationship between
disease activity (ongoing inflammation) and sodium re-tone. On the other hand, the relationship between the
glomerulus and the CCD is less obvious, and this brings tention in selected patients, but I am unaware of any
studies that have conclusively demonstrated a direct cor-up the second criterion. That is, the signal must be able
to reach the target—the CCD. The more intuitive mode relation between degree of inflammation and magnitude
of sodium retention. If there is a correlation, it obviouslyof delivery for the glomerular-derived substance (or sig-
nal) would be via tubular flow. This mode of delivery could be mediated by any of the numerous mediators
produced during inflammation. Again, I am unaware ofimplies that the one or more mediators travel down the
entire nephron but only affect the CCD. While this is any studies that have correlated GN-induced sodium
retention with the levels of any inflammatory factors.certainly possible, it seems a little less likely.
A second possible mode of delivery is suggested by Several intriguing possibilities do exist, though. For in-
stance, there is increased formation of free oxygen radi-the glomerular-tubular relationships present within the
nephron. Everyone here already knows of the relation- cals during inflammation [93, 94], and this alteration can
affect tubular function via several direct and indirectship between the macula densa and the glomerulus that
establishes tubuloglomerular feedback (albeit in this mechanisms, including the quenching of NO. Because,
as I said, NO blocks tubular sodium reabsorption, a de-case the tubule regulates the vasculature). However,
other, less well known relationships exist between the crease in NO can lead to increased tubular sodium reab-
sorption, as observed during human and experimentalglomerular structures and the distal nephron. The first
is the close proximity between the juxtaglomerular cells GN. This interaction might help explain the beneficial
effect of antioxidants during experimental GN [95, 96].of the afferent arteriole and the kallikrein-containing
cells of the connecting tubule. This association was de- In this respect, it is also interesting that decreased NO
is thought to play a role in another form of salt-sensitivescribed by Barajas et al, who found that it was present
in approximately 90% of the nephrons evaluated, com- hypertension, the Dahl salt-sensitive rat, but whether
this is true in GN-induced sodium retention requirespared to only an approximate 70% relationship between
the macula densa and the glomerulus [92]. Note that this further study.
Dr. Dennis Bueno (Attending Nephrologist, Gambrofinding does not imply that only 70% of glomeruli had
attached macula densas, but rather that the authors could Healthcare, Jujuy, Argentina): You showed that deficient
kinin production can cause sodium retention. Yet in GN,only observe these attachments in 70% of glomeruli be-
cause the contiguity of the macula densa and the glomer- kinins can be increased as part of the inflammatory pro-
cess. Can you explain this discrepancy?ular structures was short; thus the contiguity was missed
because of the thickness of the tissue slices in some Dr. Juncos: Indeed, kinin deficiency can cause sodium
retention. There are several potential explanations forcases. The connecting tubule, with its 90% relationship, is
probably contiguous to the afferent arteriole/glomerulus why increased kinins during GN do not induce natriure-
sis. First, kinins are polypeptides and might not diffusefor a greater distance than the macula densa is.
The second potential relationship is between the ef- from the glomerulus to the distal nephron; thus they
cannot exert their effect. Second, because kinins blockferent arteriole and the late distal convoluted tubule. In-
vestigators who perform experiments that require mi- CCD sodium transport by stimulating release of NO [97],
Nephrology Forum: Salt and water retention in glomerulonephritis 1191
the NO released might be quenched by the free oxygen model of GN [74]. Proteinuria thus might be an impor-
tant predictor of renal tubular damage, but not of sodiumradicals, thus rendering it ineffective. Finally, it is likely
that other mechanisms present during GN simply over- retention.
Dr. Daniel Sarano (Division of Renal Medicine, Hos-come the sodium-excreting effect of kinins.
Dr. Madias: You mentioned that, at least in some pital Centenario, Universidad Nacional de Rosario): If
the CCD is only responsible for a small fraction of so-studies on experimental models of GN, sodium retention
occurs in the presence of normal GFR and decreased dium reabsorption (3%), can a change in sodium ab-
sorption in this segment really make enough of a differ-proximal sodium reabsorption. Consequently, distal so-
dium delivery must be increased. As you know, chronic ence in the sodium balance to induce hypertension?
Dr. Juncos: Yes. Even though the CCD handles onlyincrease in distal sodium delivery triggers functional (for
example, increase in Na/K ATPase activity) and struc- a small fraction of the sodium delivered, one must re-
member that the amount of sodium excreted typically istural adaptations in the collecting duct. Might the in-
creased Na/K ATPase activity in the CCD in those less than 1% of the filtered load. Thus, even a minor
increase in the fractional reabsorption of sodium canexperimental models reflect such consequences of in-
creased distal delivery? make a large change in net sodium balance. Note that
syndromes such as primary hyperaldosteronism, the syn-Dr. Juncos: The few studies available [15, 20, 21]
suggest that the fractional delivery of sodium to the CCD drome of apparent mineralocorticoid excess, and Lid-
dle’s syndrome all are characterized by increased sodiumis increased (because of lower fractional reabsorption in
more proximal segments), but the absolute delivery of reabsorption in the CCD, and they present with volume
expansion and hypertension.sodium to the CCD is not necessarily increased (because
GFR is decreased). Thus, there does not appear to be Dr. Madias: Some studies suggest that the natriuretic
response to ANP is markedly blunted, if not abolished,a consistent increase in distal delivery that explains the
increase in Na/K ATPase activity. However, I haven’t in the absence of a normal glomerular hemodynamic
response to the compound. Are there observations onseen a study that directly tests this possibility, and thus
we cannot discard the idea that increased tubular fluid the glomerular hemodynamic response to ANP in GN?
Dr. Juncos: Radin and McCune infused exogenousvolume increases Na/K ATPase activity.
Dr. Brady: Given the evidence of sodium hyper-reab- ANP in the puromycin GN model [30]. They reported
that ANP did not promote natriuresis despite improvingsorption in the CCD, could the ability of trimethoprim
to inhibit the sodium channel in CCD cells represent an GFR, thus supporting the notion of a direct tubular effect.
Similarly, Perico et al infused ANP in rats with adriamy-unrecognized benefit of trimethoprim/sulfamethoxazole
in vasculitic patients with GN? cin-induced nephropathy and found a rise in GFR com-
parable to the rise in normal rats, in spite of which theDr. Juncos: That’s a very interesting possibility that
I don’t think has been explored. As you know, trimetho- diuretic response was inhibited [98]. Several studies have
confirmed the negligible effects of glomerular hemody-prim/sulfamethoxazole is effective in some patients with
Wegener’s granulomatosis who were resistant to cyclo- namics in the blunted diuretic response to ANP.
Dr. Mascheroni: Does the ANP resistance seen in thephosphamide, but the beneficial effects seem to be lim-
ited to the respiratory tract. On the other hand, the medulla correlate with any morphologic abnormality?
Dr. Juncos: Not with anything specific. Tubular inter-hypertension induced by vasculitis is probably not vol-
ume-dependent in most cases, so I wouldn’t expect a stitial changes might occur at some point in the course
of GN. In the puromycin GN model, cellular morphologybenefit in this group of patients.
Dr. Scuteri: What about heavy loads of proteins in the of the IMCD is normal [99]. Note that the marked dila-
tion of intercellular spaces of collecting ducts previouslytubules as a cause for the increased sodium retention?
Dr. Juncos: In early studies of unilateral puromycin reported have been shown to be an artifact caused by
fixation techniques.nephropathy, increased urinary protein excretion and
sodium retention took place only in the perfused kidney Dr. Cristian Kra¨mer (Attending Nephrologist, Hospi-
tal Ramos Mejia, Buenos Aires, Argentina): Are similar[15, 17]. This was taken as evidence of a role for protein-
uria in the increased sodium reabsorption. However, a alterations in ANP and cGMP postulated to play a role
in the sodium retention of the nephrotic syndrome? Ifcause-and-effect relationship has never been established.
In the study by Descheˆnes and Doucet in three models so, why is hypertension more prevalent in patients with
GN and edema than in nephrotic patients?of GN, proteinuria appeared 2 to 7 days after the onset
of sodium retention and remained at high levels after Dr. Juncos: Yes, disordered ANP and cGMP metabo-
lism have been described in both situations. Actually,sodium retention had ceased [28]. Finally, several studies
have found a marked dissociation between proteinuria GN and nephrosis probably have many similarities in
the way that they induce sodium retention. We knowand sodium retention in several models of GN, such as in
chronic Heymann GN and in the chronic serum sickness that in both situations edema and hypertension can be
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present, and we also know that hemodynamic changes, ated with GN by virtue of simultaneous inhibition of
ACE and neutral endopeptidase, and thus downregula-namely, increased vascular resistance, accompany hyper-
tension. Why heavy proteinuria and/or hypoproteinemia tion of Ang II and potentiation of bradykinin and natri-
uretic peptides. Is this possibility being explored?seem less often associated with hypertension is a matter
of speculation. Disparate intravascular volume distribu- Dr. Juncos: Not to my knowledge. However, as im-
plied by your question, the increased natriuretic effecttion could explain the difference.
Dr. Bueno: You showed that abnormal renal vascular of these drugs (due to decreased metabolism of ANP
and other peptides), and the associated ACE inhibitionreactivity is present during GN. Is this a primary event,
or is it secondary to the hypertension? Along these lines, can be particularly beneficial in these patients. It is inter-
esting to point out that omapatrilat is superior to capto-do you think that the altered vascular reactivity plays a
role in the pathogenesis of the hypertension during GN? pril in improving endothelium-dependent relaxation in
Dahl salt-sensitive hypertensive rats despite comparableDr. Juncos: We did see a clear alteration in vascular
reactivity that mainly was manifested as a decrease in blood pressure control [100].
Dr. Madias: I find it of great interest that puromycinendothelium-dependent vasodilation in both the radia-
tion nephritis and the puromycin GN model. This ap- GN is associated with decreased expression of aquapor-
ins in the renal medulla despite increased circulatingpears to be a primary event in these models, because it
was present before the onset of hypertension. Whether levels of AVP. You indicated that tubulointerstitial in-
jury does not appear to account for the decreased waterthis is true of other models of GN is not known.
With regard to the second part of your question, we channel expression. As you know, hypokalemia down-
regulates water channel expression, and it is likely thatare not certain about how important the altered vascular
reactivity is in the pathogenesis of GN-associated hyper- the sodium retention in the CCD associated with GN
generates potassium loss and hypokalemia. Are theretension, but it likely plays a role. I say this because if
one expands intravascular volume in a normal subject observations to support this possibility?
Dr. Juncos: Although plasma AVP levels are in-by quickly infusing saline or dextran, one finds a compen-
satory decrease in total peripheral vascular resistance creased, and aquaporin-2 and aquaporin-3 expression are
decreased in the inner medullary collecting duct of rats(TPVR), so the blood pressure remains stable. However,
if one expands intravascular volume in normal subjects with puromycin GN, there does not appear to be signifi-
cant potassium depletion in this, as well as most otherin a setting where TPVR cannot decrease, for example,
in the presence of decreased endothelial relaxation, or experimental or clinical models, of GN. This is somewhat
surprising because of increased Na/K ATPase activity.with a product that does not allow TPVR to decrease,
for example, cross-linked hemoglobin, blood pressure I do not know the reasons for the absence of hypoka-
lemia, but it might be related to diminished GFR. Beincreases. This finding might be relevant to patients with
GN because they are volume expanded and have an that as it may, it appears unlikely that hypokalemia could
be responsible for the decreased expression of aquapor-increase in TPVR, thus the concomitant hypertension.
Dr. Antonio Vilches (Professor of Medicine; Head, ins in glomerulonephritis.
Dr. Madias: Have other aspects of collecting ductRenal Section CEMIC; Buenos Aires, Argentina): The
second patient needed five drugs to control her blood function been examined in GN, such as acidification?
Dr. Juncos: I do not know of any study that has for-pressure. How do you fit the sodium retention hypothesis
with the multi-drug treatment needed in this clinical set- mally examined renal acidification in GN.
Dr. Marcelo Orias (Attending Nephrologist, Hospitalting?
Dr. Juncos: I think the refractoriness of her hyperten- Privado de Co´rdoba, Co´rdoba, Argentina): I have a hard
time understanding why the proximal tubule does notsion relates to my previous answer. Although volume
expansion is likely a primary trigger or contributor for reabsorb more sodium if GFR is low and Ang II activity
is present (as shown by the saralasin experiments). Youthe hypertension in most forms of GN, increased TPVR
is the rule in the persistent forms of hypertension. This would think that the hemodynamic factors and Ang II
would increase proximal tubule sodium reabsorption.might be due to a number of hormonal and neural re-
sponses that increase arteriolar tone and eventually Has anybody looked at why sodium reabsorption doesn’t
increase? Is there an endogenous inhibitor of Na/Kcause vascular hypertrophy. The more chronic the eleva-
tion of blood pressure, the more severe the structural ATPase? Do any of the filtered proteins inhibit the Na/
H antiporter?vascular changes that make hypertension so difficult to
treat. Thus, even though sodium retention is the primary Dr. Juncos: As far as I know, no inhibitor of sodium
reabsorption and no effect on reabsorption from proteinspathogenetic mechanism, multiple functional alterations
likely contribute to perpetuating the hypertensive status. present in the tubular lumen have been reported in GN.
Absolute proximal sodium reabsorption is diminished inDr. Madias: Vasopeptidase inhibition might offer an
attractive strategy for treatment of hypertension associ- nephrotoxic serum nephritis [22], puromycin glomerulo-
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22. Maddox D, Bennett CM, Deen WM, et al: Control of proximalforces probably explains the diminished proximal reab-
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